Results 111 to 120 of about 181,335 (186)

Development of Type II Glucose Transporter Inhibitors: Phloretin as a GLUT-2 Screening Template from <i>In Silico</i> Modeling to <i>In Vitro</i> Assessment. [PDF]

Biomedicines
Boonpech W, Srifa P, Sooksawat D, Limsakul P, Saetang J, Tipmanee V, Charupanit K, Churuangsuk C, Juncheed K.   +8 more
europepmc   +1 more source

Metabolic crosstalk in the ageing brain: astrocyte-neuron coupling as a target for homeostatic restoration and therapy. [PDF]

Transl Neurodegener
Qian L, Deng Y, Song M, Zhang Z, Cheng J, Zhu B, Wu M, Zhang H, Hu Y.   +8 more
europepmc   +1 more source

Immunohistochemical study of glucose transporter protein expression in oral lichen planus. [PDF]

Dent Res J (Isfahan)
Yas LS, Salman AS, Abdulhussain Z.
europepmc   +1 more source

Sodium-Glucose Co-Transporter 2 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis and Type 2 Diabetes: A Retrospective Observational Cohort Study Using Real-World Data. [PDF]

J Clin Med Res
Kachhadia MP, Puri P, Patel K, Topiwala U, Shaikh JD, Borad N, Gill G, Shah S, Patel J, Sanghvi HA.   +9 more
europepmc   +1 more source

Potential targets for boron transport in boron neutron capture therapy. [PDF]

Front Oncol
Wei Y, Zhu W, Chen Q, Alnufaei H, Li Y, Ricketts K.   +5 more
europepmc   +1 more source

Tissue-specific targeting of the ARF6 signalling axis for type 2 diabetes and obesity: From mechanism to nanodelivery. [PDF]

Clin Transl Med
Wang Y, He Y, Xiu Z, Wang H.
europepmc   +1 more source

Advances in the Study of Endometrial Receptivity and Glucose Metabolism Mechanisms in Insulin Resistance. [PDF]

Endocrinol Diabetes Metab
Huang SY, Chen SR, Chen WH, Zheng LT, Xu J, Shi YC, Lin S, Shi QR.   +7 more
europepmc   +1 more source

Deciphering the evolutionary history of ectoine catabolism, a compatible solute utilized by <i>Vibrio diabolicus</i> as an osmoprotectant and a nutrient source. [PDF]

Appl Environ Microbiol
Boas Lichty KE, Thomas HE, Bhide SM, Richards GP, Boyd EF.   +4 more
europepmc   +1 more source

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-Transporter-2 Inhibitors on Lean Body Mass in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. [PDF]

Diabetes Metab Res Rev
Jobanputra R, Sargeant JA, Plekhanova T, James E, Almaqhawi A, Webb DR, Davies MJ, Yates T.   +7 more
europepmc   +1 more source

Glycosylated nanoparticles for oral insulin delivery via glucose transporter to improve intestinal absorption. [PDF]

J Nanobiotechnology
Zhang Y, Ni S, Zan X, Zhu L, Yuan X.
europepmc   +1 more source